Loading...
Loading...
ICCC| Name | Value |
|---|---|
| Revenues | 8,067.2M |
| Cost of Revenue | 4,713.2M |
| Gross Profit | 3,354.0M |
| Operating Expense | 2,236.3M |
| Operating I/L | 1.1M |
| Other Income/Expense | 0.3M |
| Interest Income | 0.0M |
| Pretax | 1.4M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | 1.4M |
ImmuCell Corporation is an animal health company that develops, manufactures, and markets products to enhance the health and productivity of dairy and beef cattle. Its product line includes First Defense, a scours preventive product for newborn calves, Tri-Shield First Defense for the treatment of E. coli, coronavirus, and rotavirus, and the California Mastitis Test for detecting somatic cell counts in milk. The company also offers Dual-Force First Defense for the nutritional and feed supplement markets and is involved in developing Re-Tain, an intramammary treatment for subclinical mastitis in lactating dairy cows. ImmuCell sells its products through animal health distributors.
